Ocean Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Net Income	-98.59	-17.36	-62.34
Share-Based Compensation	1.02	12.38	56.55
Other Operating Activities	88.98	3.99	4.74
Operating Cash Flow	-8.6	-0.99	-1.05
Share Issuance / Repurchase	14.26	0	1.02
Debt Issued / Paid	6.01	0.74	0
Other Financing Activities	-10.76	0.23	0.1
Financing Cash Flow	9.51	0.97	1.11
Net Cash Flow	0.92	-0.03	0.06
Free Cash Flow	-8.6	-0.99	-1.05
Free Cash Flow Per Share	-0.32	-0.06	-0.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).